Phillip James Consulting’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.11K Hold
5
– – ﹤0.01% 256
2026
Q2
$1.81K Hold
5
– – ﹤0.01% 224
2026
Q1
$1K Buy
+5
New +$1.78K ﹤0.01% 262

Other funds holding AMGN

Phillip James Consulting's AMGN Position: Q3 2026 in Review

Phillip James Consulting held its Amgen (AMGN) position steady in Q3 2026 at 5 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Phillip James Consulting first reported a position in AMGN in Q1 2026 and has held it in 3 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Phillip James Consulting held 5 shares of Amgen worth $2.11K as of Q3 2026.
  • Phillip James Consulting left its Amgen share count unchanged in Q3 2026.
  • Amgen made up ﹤0.01% of Phillip James Consulting's portfolio in Q3 2026, its #256 holding.
  • Phillip James Consulting first reported a position in Amgen in Q1 2026 and has held it in 3 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Phillip James Consulting's 13F filing for Q3 2026, filed 3 Nov 2026.